Drug Crisis: What is Texas, Nueces, Corpus Christi State Doing to Control the Epidemic
Pre-Conditions for the Growth of Addiction
The United States faces a severe drug addiction crisis characterized by widespread use across multiple substance categories. Approximately 27.1% of males and 22.7% of females have used drugs in the past year, with opioid abuse affecting 1.2% of males and 0.9% of females. The crisis extends beyond opioids to include significant misuse of cocaine, methamphetamines, prescription stimulants, and other controlled substances, creating a multifaceted public health emergency that impacts communities at every socioeconomic level.
The opioid epidemic’s origins trace to the 1990s when pharmaceutical companies aggressively marketed prescription opioids, particularly OxyContin, downplaying addiction risks and leading to widespread legitimate prescriptions that fueled dependency. As prescription opioids became more tightly regulated, many individuals transitioned to illicit heroin, and subsequently to fentanyl—a synthetic opioid 50-100 times more potent than morphine. Mexican drug cartels, including the Sinaloa Cartel, began mass-producing fentanyl and mixing it into heroin and cocaine supplies, dramatically increasing overdose deaths. The COVID-19 pandemic further exacerbated the crisis by disrupting treatment programs, increasing social isolation, and expanding illicit drug availability. Additionally, the rise of counterfeit pills containing fentanyl and emerging synthetic drugs like nitazene compounds has created new layers of danger that users often cannot detect.
Social and Economic Impacts
The opioid and drug crisis has created unprecedented strain on the healthcare system, with emergency departments overwhelmed by overdose cases, non-fatal overdose interventions, and related complications. For every fatal overdose, approximately 8.4 non-fatal overdoses occur, creating massive demand for emergency care, toxicology services, and hospital bed availability. The crisis has also driven increased costs for treatment programs, mental health services, and chronic disease management related to addiction. Healthcare infrastructure in affected communities has been stretched thin, with some facilities dedicating significant resources solely to addiction-related emergencies, diverting attention and funding from other critical medical needs. Prescription opioid exposure among children under 5 has increased by 93% annually over a nine-year period, indicating growing accidental poisonings and the burden on pediatric emergency care.
Beyond healthcare, the addiction crisis has devastated public safety and economic productivity. Communities experience increased crime rates, property theft, and violence associated with drug trafficking and addiction-related behavior. Law enforcement agencies allocate substantial resources to drug interdiction, investigations, and incarceration, diverting funds from other public safety priorities. Workplace productivity suffers as employers deal with absenteeism, reduced work performance, and costs associated with employee assistance programs and treatment services. The criminal justice system bears enormous costs through arrests, prosecution, and incarceration of individuals with substance use disorders, with many states spending billions annually on drug-related offenses. Additionally, the loss of life and disability from addiction removes productive workers from the economy, reduces tax revenue, and increases dependence on social safety net programs.
Federal Countermeasures
The federal government has implemented several evidence-based initiatives to combat the drug crisis:
Expanded Access to Narcan and Overdose Reversal Programs
The federal government has prioritized making naloxone (Narcan) widely available through community distribution programs, harm reduction initiatives, and emergency services. This initiative provides funding and support for police departments, fire departments, and community organizations to equip first responders with multiple doses of Narcan, recognizing that fentanyl overdoses often require more than one dose due to the drug’s potency. The program targets communities with the highest overdose rates and trains both professionals and laypersons in naloxone administration. Research demonstrates that widespread Narcan availability has prevented thousands of deaths by reversing respiratory depression during overdoses, making it one of the most direct and effective interventions available.
Substance Use Disorder Treatment Expansion ($21.8 Billion Investment)
Federal funding of $21.8 billion has been allocated to expand access to evidence-based treatment for substance use disorders and overdose prevention services. This investment targets underserved communities, rural areas, and populations with limited treatment access, including individuals in criminal justice settings and those experiencing homelessness. The funding supports medication-assisted treatment (MAT) programs using methadone and buprenorphine, behavioral therapies, peer support services, and recovery housing. By increasing treatment capacity and reducing barriers to care such as cost and stigma, this initiative addresses the fundamental need for long-term recovery support rather than relying solely on emergency interventions.
Harm Reduction Interventions ($459 Million Investment)
Federal investment of $459 million has expanded harm reduction programs designed to reduce the negative consequences of drug use for individuals and communities. These programs include supervised consumption facilities, needle and syringe exchange programs, and drug testing services that help prevent disease transmission and provide connection points to treatment services. Harm reduction approaches recognize that while addiction treatment is essential, immediate interventions can save lives and prevent disease transmission among people who are not yet ready for recovery. This funding supports the operational costs of these services and helps overcome local opposition and regulatory barriers that have historically limited program expansion.
Opioid Settlement Funds Distribution and State Programs ($1.6 Billion to Texas)
Multi-state litigation settlements with pharmaceutical companies have directed billions to states for opioid crisis response, with Texas receiving $1.6 billion over an 18-year period. These funds are managed through state-level councils and allocated to prevention, treatment, recovery support, and harm reduction programs tailored to local needs. The settlement represents accountability for pharmaceutical companies’ role in marketing practices that fueled the crisis and provides sustained funding for evidence-based interventions. States must prioritize initiatives supported by research data, creating opportunities for comprehensive, long-term strategic responses rather than ad-hoc emergency measures.
Prevention and Early Intervention Education Campaigns
Federal funding supports nationwide public education campaigns targeting youth, healthcare providers, and communities to prevent drug misuse initiation and promote awareness of addiction risks. These campaigns highlight the specific dangers of fentanyl and emerging synthetic drugs, educate about overdose recognition and response, and reduce stigma associated with addiction and treatment. Prevention initiatives in schools provide evidence-based curricula on substance abuse risks and healthy coping mechanisms, while provider-focused training improves prescribing practices and recognition of addiction symptoms. By combining youth-focused prevention with public awareness, these campaigns create cultural shifts that support prevention at multiple life stages and complement treatment and harm reduction efforts.
Texas Case – The Numbers Speak for Themselves
Texas has experienced significant drug-related mortality, though the state’s rate remains notably lower than many other states. The state had an average drug-related mortality rate of 11 deaths per 100,000 residents from 1999-2023, less than one-third that of West Virginia’s 36 deaths per 100,000. However, Texas drug deaths peaked at 19 per 100,000 in 2022 before declining 12% in 2024, though they remain above pre-pandemic levels. For individuals seeking support in regions like Corpus Christi, more information on local Narcotics Anonymous meetings can be found at https://www.wfmh.org/na/texas/nueces/corpus-christi. Across specific regions, Harris County (Houston area) reported 942 accidental overdose deaths in 2024, representing a 14.1% decline from previous years. Dallas County experienced more dramatic progress, with fentanyl-related deaths dropping from 282 in 2023 to approximately 140 as of November 2024—a decline exceeding 50%.
One key factor explaining Texas’s relatively lower overdose rate compared to national trends is the state’s lower fentanyl adoption rate. Despite Texas’s proximity to the southern border and significant fentanyl trafficking routes, only 34% of Texas overdoses between 2019 and 2023 involved fentanyl, compared to the national rate of 62%. In Tarrant County, synthetic narcotics and psychostimulants tied as the leading drug categories in overdose deaths, with 39% of fatal overdoses involving each substance type, indicating a more diversified drug death profile than pure fentanyl-focused crises seen in other regions.
Mortality Statistics for Texas Regions:
| Region | Year | Deaths/Deaths Rate | Notable Trend |
|---|---|---|---|
| Harris County (Houston) | 2024 | 942 deaths | 14.1% decline from prior year |
| Dallas County | 2023 | 282 fentanyl-related deaths | — |
| Dallas County | Nov 2024 | ~140 fentanyl-related deaths | 50% decline year-over-year |
| Tarrant County | 2023 | 503 fatal overdoses | 90% unintentional; 185 fentanyl-related |
| Texas (statewide) | 2024 | Down 12% from 2023 | Remains above pre-pandemic levels |
State Programs and Response Strategies:
Texas Opioid Abatement Fund Council
Established in 2021, the Opioid Abatement Fund Council manages Texas’s $1.6 billion settlement from pharmaceutical companies to be distributed over 18 years. The Council develops comprehensive strategies for allocating funds across prevention, treatment, recovery support, and harm reduction initiatives statewide, ensuring evidence-based spending decisions. This program provides Texas with sustained, dedicated funding for long-term opioid crisis interventions and allows the state to develop coherent, strategic responses rather than responding reactively to crises.
Opioid Response Teams and Emergency Department Integration
Texas has deployed specialized opioid response teams and integrated peer navigators into hospital emergency departments across major metropolitan areas, particularly in the Dallas-Fort Worth region. These teams provide immediate intervention for individuals experiencing overdoses, connect patients with treatment resources, and follow up with sustained recovery support. The integration of peer navigators—individuals with lived experience of addiction and recovery—creates trusted touchpoints for vulnerable patients and significantly improves treatment engagement and outcomes.
Dallas County Overdose Mapping and Real-Time Response Technology
Dallas County has implemented overdose mapping technology that tracks suspected overdose interventions and overdose locations in real-time, making critical data immediately accessible to first responders and public health officials. Since 2023, Dallas has recorded 3,903 suspected overdose interventions through this system, creating a dynamic database that informs resource allocation and targeted prevention efforts. The system enables rapid response to emerging hotspots and helps identify trends in overdose patterns, drug types, and vulnerable populations, facilitating evidence-based deployment of harm reduction and treatment services.
Emergency Equipment Distribution for Law Enforcement
Dallas County District Attorney’s Office allocated $150,000 in asset forfeiture funds to equip Dallas Police Department patrol cars with Narcan doses and fentanyl-detection equipment. Every Dallas patrol car now carries three doses of Narcan, the recommended amount to effectively reverse fentanyl overdoses, recognizing that fentanyl’s potency often requires multiple doses. This program directly places life-saving medication in the hands of first responders and represents investment in immediate, field-level intervention capabilities.
Approaches in Neighboring Regions
Texas’s neighboring states employ varied strategies for addressing the drug crisis:
- New Mexico
- New Mexico has implemented comprehensive harm reduction and overdose prevention initiatives focusing on community-based drug testing services and medication-assisted treatment accessibility. The state has integrated naloxone distribution through multiple channels including pharmacies, community health centers, and law enforcement agencies, making the medication widely available without prescription barriers. New Mexico has also invested heavily in recovery housing and peer support services that provide sustained aftercare for individuals transitioning from acute overdose intervention to long-term recovery. While New Mexico’s overdose mortality rate exceeds Texas’s, the state’s strategic focus on harm reduction infrastructure and treatment access represents an alternative approach to combating the crisis through accessibility rather than restrictive measures.
- Louisiana
- Louisiana has developed integrated treatment and criminal justice diversion programs that connect individuals arrested for drug offenses with treatment rather than incarceration. The state operates specialized drug courts that prioritize rehabilitation over punishment, significantly reducing recidivism and overdose deaths among justice-involved populations. Louisiana has also expanded access to medication-assisted treatment in correctional facilities and community settings, recognizing that continuous treatment access during critical transition periods prevents relapse. Like New Mexico, Louisiana’s overdose rate exceeds Texas’s, but the state’s emphasis on treatment-oriented criminal justice responses addresses addiction as a public health issue rather than primarily a criminal justice problem.
- Oklahoma
- Oklahoma has prioritized prescription monitoring programs and healthcare provider education to reduce inappropriate opioid prescribing as a primary prevention strategy. The state operates a robust prescription drug monitoring program that allows healthcare providers to access patients’ medication history and identify high-risk prescribing patterns before they contribute to addiction. Oklahoma has also invested in provider training on pain management alternatives, addiction recognition, and appropriate opioid use, creating a focused approach to preventing prescription opioid-related addiction at the source. This upstream prevention approach complements downstream treatment and harm reduction efforts and represents a distinct strategy focused on controlling supply through prescriber behavior modification.
Is It Possible to Stop the Crisis? Looking to the Future
Approaches with Demonstrated Potential for Effectiveness:
- Medication-Assisted Treatment (MAT) with Buprenorphine and MethadoneResearch consistently demonstrates that MAT significantly reduces illicit opioid use, improves treatment retention, and decreases overdose mortality. These medications address the neurobiological basis of opioid addiction by reducing cravings and withdrawal symptoms, allowing individuals to stabilize and engage in recovery. Expanding MAT access through telehealth, primary care integration, and reduced regulatory barriers has proven effective in reaching underserved populations and improving outcomes at scale.
- Comprehensive Harm Reduction ProgramsEvidence demonstrates that integrated harm reduction services including supervised consumption facilities, needle exchange programs, drug testing services, and peer support reduce disease transmission, prevent overdose deaths, and create pathways to treatment. Harm reduction approaches meet people where they are without requiring abstinence as a prerequisite, reducing barriers to engagement and providing crucial touchpoints for vulnerable populations.
- Early Intervention and Prevention EducationSchool-based prevention programs and community awareness campaigns targeting youth before drug initiation have demonstrated effectiveness in reducing initiation rates and delaying first use. Provider-focused education improving prescribing practices and addiction recognition prevents iatrogenic addiction and enables early intervention before severe addiction develops.
- Treatment with Sustained Aftercare and Peer SupportRecovery outcomes improve dramatically when acute treatment is followed by sustained peer support, recovery housing, and ongoing counseling. Peer navigators and individuals with lived experience of recovery provide credible, relatable support that professionals alone cannot provide, improving engagement and preventing relapse during vulnerable transition periods.
- Interagency Data Sharing and Real-Time Response CoordinationSystems that integrate overdose data across law enforcement, public health, emergency services, and treatment providers enable rapid identification of emerging threats and targeted resource deployment. Real-time coordination allows response teams to reach at-risk individuals quickly and adjust prevention strategies based on evolving drug threats like emerging synthetic compounds.
Approaches with Limited Effectiveness or Significant Drawbacks:
- Incarceration as Primary ResponseRelying predominantly on criminal justice incarceration for drug offenses fails to address underlying addiction as a medical condition and creates barriers to employment, housing, and treatment access that increase recidivism. Research demonstrates that individuals incarcerated for drug offenses without concurrent treatment experience higher relapse and overdose rates upon release, particularly when incarceration interrupts existing treatment.
- Abstinence-Only Approaches Without Medical SupportRequiring complete abstinence without medical intervention ignores the neurobiological basis of opioid addiction and places unrealistic demands on individuals whose brain chemistry has been altered by chronic opioid use. Abstinence-only approaches without medication support or supervised environments result in high relapse rates and disproportionately high mortality during relapse periods when tolerance has decreased.
- Stigma-Based Messaging and Punitive ApproachesPublic messaging that portrays addiction as a moral failing or character defect rather than a medical condition increases stigma, delays treatment-seeking, and reduces community support for evidence-based interventions. Stigmatizing approaches drive addiction underground, prevent social connection and support, and make individuals less likely to seek help or receive necessary medical care.
- Supply-Side Enforcement Alone Without Demand ReductionLaw enforcement efforts targeting drug supply without concurrent treatment, prevention, and harm reduction show limited effectiveness in reducing overall drug use or overdose deaths, as suppressing one supply source leads to substitution with alternative drugs or sources. Mexican cartels have repeatedly demonstrated ability to synthesize new drugs (such as nitazene) when existing opioids face enforcement pressure, requiring parallel demand-reduction strategies.
- Lack of Continuity in Treatment and AftercareTreatment programs without integrated discharge planning, sustained peer support, and connection to ongoing mental health services result in rapid relapse after acute treatment completion. The critical 30-90 day period following treatment discharge requires intensive support and monitoring to prevent return to active addiction, yet many programs terminate intensive support immediately upon discharge.
Conclusions and Recommendations
Addressing the drug crisis requires states and communities to embrace a fundamental reorientation toward public health responsibility. Rather than treating addiction primarily as a criminal justice issue, jurisdictions must recognize substance use disorders as complex medical and social conditions requiring comprehensive, integrated responses. Texas demonstrates that progress is possible—the state’s relatively lower overdose mortality rate compared to national averages, combined with recent declines in fentanyl deaths in Dallas and Harris Counties, reflects the cumulative impact of evidence-based interventions including harm reduction, treatment accessibility, and coordinated emergency response.
Each state will develop its own approach reflecting local conditions, political context, and available resources. However, successful strategies consistently rest on three foundational principles. First, reliable data systems that track overdose patterns, drug composition, and intervention outcomes must drive resource allocation and strategy adjustment. Second, open dialogue involving individuals with lived experience of addiction, treatment providers, law enforcement, public health officials, and community members must inform policy development and prevent siloed responses. Third, long-term commitment to supporting individuals through recovery—including sustained medication access, peer support, housing stability, and employment opportunities—must replace both punitive responses and temporary, crisis-driven interventions. When states invest in these evidence-based foundations, progress emerges measurably, lives are saved, and communities move toward sustainable recovery culture.